Bristol-Myers Squibb: Neoplasms trials

The registry lists 106 Neoplasms studies with Bristol-Myers Squibb as lead sponsor. 7 are open to participants now and 28 have results posted.

Phase 1 81Phase 2 30Phase 3 5Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00101608Phase 2
• BMS-599626 in Patients With Advanced Solid MalignanciesCompletedNCT00095537Phase 1
• Study of ABI-007 and Taxol in Patients With Metastatic Breast CancerCompletedNCT00046527Phase 3
• ABI-007 in Taxol Resistant Patients With Metastatic Breast CancerCompletedNCT00046514Phase 2
• A Trial of ABI-007 in Patients With Advanced Non-Hematologic MalignanciesCompletedNCT00046423Phase 1
• Carboplatin and Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00024284Phase 1